FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma
Article in Heliyon (October 2023)
The most recent citing publications are shown below. View all 53 publications that cite this research output on Dimensions.
Article in Heliyon (October 2023)
Article in Environmental Toxicology (June 2023)
Article in Frontiers in Immunology (June 2023)